IPPRA / Grant Monitor

2026-09-06
← Board

Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)

PAR-25-039 · National Institutes of Health

biomedical clinical mental behavioral health public health ai data science Health

Closes
2026-09-07 · 1 d
Award ceiling
Award floor
Program funding
Expected awards
Cost sharing
No
Posted
2024-11-18
Instrument
Grant
Characterization · gpt-5.4-mini · 2026-07-07

R01 grants support translational research on the emergence and course of schizophrenia and related disorders in mid- to late-life, including studies that identify prevention and treatment targets.

Funds
applied research
University
direct
social behavioral
substantial
life biomedical
central
computational data
substantial

⚑ R01 Clinical Trial Optional · No cost ceiling listed (award ceiling shown as $0) · Foreign organizations and multiple minority-serving and tribal/territorial applicant classes are explicitly eligible

8 / 100 IPPRA team judgment

This is a biomedical/clinical psychiatry R01 on schizophrenia mechanisms and treatment trajectories, which is far outside this team’s survey, risk communication, hazard perception, and policy-research portfolio. The only possible overlap is very broad public-health framing, but none of the dossier members publishes in mental health disorder biology or clinical trials.

JUDGED AGAINST THE ROSTER'S PUBLICATION DOSSIER · GPT-5.4-MINI · 2026-07-07

Unit fits — one characterization, each unit's own rules

Physical Sciences & Engineering (demo) 80 strong technical depth: substantial; funds applied research
IPPRA 58 good peripheral portfolio topic: public_health; signature methods: surveys longitudinal; social/behavioral work is substantial; funds applied research; biomedical core — IPPRA health lane is communication/crisis/policy (capped); clinical-trial/biomedical core — IPPRA angle is policy/community (capped)
Tom Love Innovation Hub 30 weak funds applied research; deep-tech content

Description

Although the majority living with schizophrenia and related disorders are over 35 years old, including those first diagnosed and those aging with the illness, the mechanisms underlying the generation and trajectory of the illness remain poorly understood. The purpose of this initiative is to advance translational research to better understand the emergence and trajectory of schizophrenia and related disorders in mid to late life, and to identity targets for future development of prevention and treatment efforts.

Eligibility

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Apply

View on Grants.gov → CONTACT: National Institutes of Health <grantsinfo@nih.gov>

Proposal brief SEE AN EXAMPLE →

A one-page internal memo: fit assessment, submission requirements, document scaffold, and next steps dated back from the deadline — tailored to your project idea if you add one.

ONE LLM CALL (~1¢) · CACHED · REQUIRES STAFF KEY

Proposal shell · National Institutes of Health conventions SEE AN NIH EXAMPLE →

Funder-faithful document skeletons — National Institutes of Health's document set with section headings, page limits, reviewer guidance, and writing prompts; add a project idea to get [DRAFT] starter bullets. Download as .md for Word or Overleaf.

ONE LLM CALL (~2-3¢) · CACHED · SCAFFOLDING, NOT GHOSTWRITING